BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20191114T130000Z
DTEND:20191114T150000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:The Future of Cancer Care
DESCRIPTION:American Cancer Society's 4th Annual Policy Forum -- The Future of Cancer Care: The Role of Biomarkers in Advancing Personalized Medicine\n\nThis event will examine the current impact and future potential of biomarkers in cancer research\, diagnosis and treatment and discuss advancements and barriers to new technological discoveries. Participants will include key stakeholders throughout the oncology community\, including leaders in life sciences\, health care systems\, academia\, provider groups\, patient advocacy\, public policy\, business\, and others. \n\nPresenters Include:\n\nPratheesh Sathyan\, Ph.D. - National Lead Medical Science Liaison\, Foundation Medicine\n\nBarbara Moehring - Director of Clinical Development and Medical Affairs Oncology at Boehringer Ingelheim\n\nJairaj A. Puthenveettil\, Ph.D.\, M.B.A- Associate Director\, Oncology Health Systems Bristol-Myers Squibb\n\nDaniel P. Petrylak\, MD - Professor of Medicine (Medical Oncology) and of Urology\; Co-Leader\, Cancer Signaling Networks\, Yale Cancer Center\n\nAlpesh J. Amin\, M.D. - Medical Director US Oncology Medical\, Novartis\n\nState Representative Dr. William Petit\, House Ranking Member of the Public Health Committee will moderate the program.
X-ALT-DESC;FMTTYPE=text/html:<strong><span style="font-family:calibri\,sans-serif\;"><span style="font-size:11.0pt\;">American Cancer Society&#39\;s 4th Annual Policy Forum -- The Future of Cancer Care: The Role of Biomarkers in Advancing Personalized Medicine</span></span></strong><br />\n<span style="color:black\;"><span style="font-family:calibri\,sans-serif\;"><span style="font-size:12.0pt\;">This event will examine the current impact and future potential of biomarkers in cancer research\, diagnosis and treatment and discuss advancements and barriers to new technological discoveries. Participants will include key stakeholders throughout the oncology community\, including leaders in life sciences\, health care systems\, academia\, provider groups\, patient advocacy\, public policy\, business\, and others.&nbsp\;<br />\nPresenters Include:</span></span></span><br />\n<strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:#201F1E\;"><span style="font-size:12.0pt\;">Pratheesh Sathyan</span></span></span></em></strong><strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">\, Ph.D. -&nbsp\;</span></span></span></em></strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:#201F1E\;"><span style="font-size:12.0pt\;">National Lead Medical Science Liaison\, Foundation Medicine</span></span></span><br />\n<strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Barbara Moehring&nbsp\;</span></span></span></em></strong><strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">-&nbsp\;</span></span></span></strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Director of Clinical Development and Medical Affairs Oncology at Boehringer Ingelheim</span></span></span><br />\n<strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Jairaj A. Puthenveettil\, Ph.D.\, M.B.A</span></span></span></em></strong><strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">-&nbsp\;</span></span></span></strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Associate Director\, Oncology Health Systems Bristol-Myers Squibb</span></span></span><br />\n<strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:#201F1E\;"><span style="font-size:12.0pt\;">Daniel P. Petrylak\, MD -&nbsp\;</span></span></span></em></strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:#201F1E\;"><span style="font-size:12.0pt\;">Professor of Medicine (Medical Oncology) and of Urology\; Co-Leader\, Cancer Signaling Networks\, Yale Cancer Center</span></span></span><br />\n<strong><em><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Alpesh J. Amin\, M.D.</span></span></span></em></strong><strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">&nbsp\;-&nbsp\;</span></span></span></strong><span style="border:none windowtext 1.0pt\;padding:0in\;background:white\;"><span style="color:black\;"><span style="font-size:12.0pt\;">Medical Director&nbsp\;US Oncology Medical\, Novartis</span></span></span><br />\n<span style="color:#191919\;"><span style="font-size:12.0pt\;">State Representative&nbsp\;<span style="background:white\;">Dr. William Petit\,&nbsp\;</span>House Ranking Member of the Public Health Committee will moderate the&nbsp\;program</span></span><span style="color:#131313\;"><span style="font-size:12.0pt\;">.</span></span><br />\n<br />\n&nbsp\;
LOCATION:Pond House Cafe 1555 Asylum Ave. West Hartford\, CT
UID:e.3150.2575
SEQUENCE:3
DTSTAMP:20260428T015918Z
URL:https://business.whchamber.com/events/details/the-future-of-cancer-care-2575
END:VEVENT

END:VCALENDAR